Patents by Inventor Jill P. Adler-Moore

Jill P. Adler-Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation and process
    Patent number: 5688525
    Abstract: A process for preparing a liposomal cyclosporin therapeutic formulation, which comprises dissolving a combination of a neutral and negatively charged phospholipid and a cyclosporin in an organic solvent; drying the solution to form a solid phase, and hydrating the solid phase in an aqueous solution having a pH ranging from 7.5 to 9.5.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: November 18, 1997
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Jill P. Adler-Moore, William A. Ernst
  • Liposomal cyclosporin pharmaceutical formulation
    Patent number: 5683714
    Abstract: An improved liposomal cyclosporin therapeutic formulation, comprising phosphatidylcholine, phosphatidylglycerol and a cyclosporin in a mole ratio of from 25:3:1 to 17:3:1 is described. The formulation includes unilamellar vesicles having reduced toxicity. The formulation is used as an immunosuppressive agent and is an enhancer of the efficacy of antineoplasties for drug resistant cancer cells. A method is also provided for inhibiting the growth of cancer cells.
    Type: Grant
    Filed: April 5, 1995
    Date of Patent: November 4, 1997
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Jill P. Adler-Moore, Su-Ming Chiang
  • Pharmaceutical formulation and process
    Patent number: 5670166
    Abstract: A process for preparing a liposomal cyclosporin therapeutic formulation, which comprises dissolving a combination of a neutral and negatively charged phospholipid and a cyclosporin in an organic solvent; drying the solution to form a solid phase, and hydrating the solid phase in an aqueous solution having a pH ranging from 7.5 to 9.5.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 23, 1997
    Assignee: NeXstar Pharmaceuticals
    Inventors: Jill P. Adler-Moore, William A. Ernst
  • Pharmaceutical formulation and process
    Patent number: 5660856
    Abstract: A process for preparing a liposomal cyclosporin therapeutic formulation, which comprises dissolving a combination of a neutral and negatively charged phospholipid and a cyclosporin in an organic solvent; drying the solution to form a solid phase, and hydrating the solid phase in an aqueous solution having a pH ranging from 7.5 to 9.5.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: August 26, 1997
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Jill P. Adler-Moore, William A. Ernst